Who invested in Genetix Biotherapeutics Inc.

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round: VentureFeb 2025
Investors: 5

See who backed them

The rounds

Feb 2025
VentureAmount undisclosed
Source recorded

Founders and team

From Genetix Biotherapeutics Inc.'s own website: 6 on the team.

Brian RileyPresident & Chief Technical Officer
David MeekChief Executive Officer
Adrian ChaissonChief Corporate Development & Strategy Officer
Continue ExploringChief Corporate Development & Strategy Officer
Joanne LagerChief Medical Officer
Wendy DiCiccoChief Financial & Administrative Officer

Everyone who backed them

RA Capital ManagementPrivate equity1round

ARCH Venture PartnersVC firm1round

Forbion Capital PartnersPrivate equity1round

SanofiInvestment firm1round

Hercules CapitalVenture debt1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Genetix Biotherapeutics Inc.

Who invested in Genetix Biotherapeutics Inc.?

Genetix Biotherapeutics Inc.'s investors include RA Capital Management, ARCH Venture Partners, Forbion Capital Partners, Sanofi and Hercules Capital.

How much has Genetix Biotherapeutics Inc. raised?

Genetix Biotherapeutics Inc. has raised 1 round since 2025, none with a disclosed amount.

When did Genetix Biotherapeutics Inc. last raise?

Genetix Biotherapeutics Inc.'s most recent round was a Venture in Feb 2025.

Who backed Genetix Biotherapeutics Inc. first?

Genetix Biotherapeutics Inc.'s first round on record, in Feb 2025, was backed by RA Capital Management, ARCH Venture Partners and Forbion Capital Partners and 2 others.